Fragment-based drug discovery (FBDD)

FBDD is the powerful new kid on the bock when it comes to drug discovery. We provide seamless access to one of the world’s best FBDD facilities, in-house! Find out more about this through Monash Fragment Platform (MFP).

Fragment ligands can feed directly into ATMCF for optimisation towards lead series, then pre-clinical and clinical candidates.